Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cognitive behavioral therapy for insomnia (CBT-I) is an evidence-based, multi-component psychological treatment designed to alleviate insomnia by modifying maladaptive sleep-related thoughts and behaviors. Treatment commonly integrates components such as sleep restriction therapy, stimulus control, sleep hygiene education, cognitive therapy aimed at restructuring dysfunctional beliefs about sleep, and relaxation techniques. CBT-I is typically delivered over 6–8 sessions by trained behavioral sleep medicine providers in either individual or group format. It is considered the first-line non-pharmacological intervention for chronic insomnia, with efficacy equal to sleep medications but without their adverse effects[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cognitive behavioral therapy for insomnia (CBT-I).